{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T16:40:05Z","timestamp":1750437605740,"version":"3.41.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejphar.2025.177682","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T09:08:43Z","timestamp":1745572123000},"page":"177682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel retinoic acid receptor-\u03b1 inhibitor, AS4040605, inhibits ILC2 activity"],"prefix":"10.1016","volume":"999","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3943-6983","authenticated-orcid":false,"given":"Chihiro","family":"Hara-Tsuchiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9152-5798","authenticated-orcid":false,"given":"Satoru","family":"Ujihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho-ichi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Kitanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuma","family":"Jono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruna","family":"Sasaki-Iwaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejphar.2025.177682_bib1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41577-020-0282-9","article-title":"Plasticity of innate lymphoid cell subsets","volume":"20","author":"Bal","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177682_bib2","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.str.2019.05.001","article-title":"Interplay of protein disorder in retinoic acid receptor heterodimer and its corepressor regulates gene expression","volume":"27","author":"Cordeiro","year":"2019","journal-title":"Structure"},{"key":"10.1016\/j.ejphar.2025.177682_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/9780470559277.ch110252","article-title":"Selecting, acquiring, and using small molecule libraries for high-throughput screening","volume":"4","author":"Dandapani","year":"2012","journal-title":"Curr Protoc Chem Biol"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177682_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1089\/adt.2010.0305","article-title":"Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening","volume":"9","author":"Eglen","year":"2011","journal-title":"Assay Drug Dev. Technol."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177682_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41577-020-0301-x","article-title":"Heterogeneity in the initiation, development and function of type 2 immunity","volume":"20","author":"Gause","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177682_bib6","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood-2013-11-427781","article-title":"Human innate lymphoid cells","volume":"124","author":"Hazenberg","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177682_bib7","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/eji.201848006","article-title":"Expression of c-Kit discriminates between two functionally distinct subsets of human type 2 innate lymphoid cells","volume":"49","author":"Hochd\u00f6rfer","year":"2019","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177682_bib8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4049\/jimmunol.1101270","article-title":"Identification of innate IL-5\u2013Producing cells and their role in lung eosinophil regulation and antitumor immunity","volume":"188","author":"Ikutani","year":"2012","journal-title":"J. Immunol."},{"issue":"51","key":"10.1016\/j.ejphar.2025.177682_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi3770","article-title":"JAK3 inhibitor suppresses multipotent ILC2s and attenuates steroid-resistant asthma","volume":"9","author":"Kim","year":"2023","journal-title":"Sci. Adv."},{"issue":"25","key":"10.1016\/j.ejphar.2025.177682_bib10","doi-asserted-by":"crossref","first-page":"19401","DOI":"10.1074\/jbc.M002472200","article-title":"Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands. Influence of DNA-Heterodimer interactions","volume":"275","author":"Klein","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.ejphar.2025.177682_bib11","doi-asserted-by":"crossref","first-page":"8551","DOI":"10.1002\/anie.201300683","article-title":"Design and synthesis of minimalist terminal alkyne-containing diazirine photo-crosslinkers and their incorporation into kinase inhibitors for cell- and tissue-based proteome profiling","volume":"52","author":"Li","year":"2013","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177682_bib12","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.ejphar.2025.177682_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mj\u00f6sberg","year":"2011","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177682_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrd.2017.111","article-title":"Opportunities and challenges in phenotypic drug discovery: an industry perspective","volume":"16","author":"Moffat","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177682_bib15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nprot.2015.047","article-title":"Isolation and analysis of group 2 innate lymphoid cells in mice","volume":"10","author":"Moro","year":"2015","journal-title":"Nat. Protoc."},{"issue":"7280","key":"10.1016\/j.ejphar.2025.177682_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"issue":"7293","key":"10.1016\/j.ejphar.2025.177682_bib17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"Neill","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177682_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.757967","article-title":"Tissue-specific molecular markers and heterogeneity in type 2 innate lymphoid cells","volume":"12","author":"Olgu\u00edn-Mart\u00ednez","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177682_bib19","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/cea.12568","article-title":"Vitamins A and D have antagonistic effects on expression of effector cytokines and gut-homing integrin in human innate lymphoid cells","volume":"45","author":"Ruiter","year":"2015","journal-title":"Clin. Exp. Allergy"},{"issue":"7","key":"10.1016\/j.ejphar.2025.177682_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072365","article-title":"Expression and role of IL-1\u03b2 signaling in chondrocytes associated with retinoid signaling during fracture healing","volume":"21","author":"Shimo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6169","key":"10.1016\/j.ejphar.2025.177682_bib21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1126\/science.1247606","article-title":"Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity","volume":"343","author":"Spencer","year":"2014","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177682_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41385-018-0130-4","article-title":"Pulmonary group 2 innate lymphoid cells: surprises and challenges","volume":"12","author":"Starkey","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ejphar.2025.177682_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2016.03.036","article-title":"Inhibition of c-Rel DNA binding is critical for the anti-inflammatory effects of novel PIKfyve inhibitor","volume":"780","author":"Terajima","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177682_bib24","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ejphar.2025.177682_bib25","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20151448","article-title":"Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infection","volume":"213","author":"Wilhelm","year":"2016","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177682_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"issue":"21","key":"10.1016\/j.ejphar.2025.177682_bib27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.drudis.2013.07.001","article-title":"Phenotypic screens as a renewed approach for drug discovery","volume":"18","author":"Zheng","year":"2013","journal-title":"Drug Discov. Today"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925004364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925004364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T16:06:42Z","timestamp":1750435602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925004364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":27,"alternative-id":["S0014299925004364"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177682","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel retinoic acid receptor-\u03b1 inhibitor, AS4040605, inhibits ILC2 activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177682"}}